0 results for 'Janssen Pharmaceutical'
'How Can It Be Enough?': Thousands Have Agreed to the Risperdal Settlement. A Few Holdouts Remain
According to attorneys leading the litigation, more than 5,600 have agreed to the settlement, which is about 94% of the potential 6,000 claims for the bulk settlement. The lawyers said 99.9% of claimants have chosen to accept their settlement offers.Up to $1.1 Billion: Inside the Settlement Resolving Most of Philadelphia's Risperdal Cases
According to settlement records, the settlement's group expenses were $33 million, with additional costs expected to be incurred.Blank Rome Files Trade Secrets Suit Against Former J&J Employee for Departing to Pfizer
This suit was surfaced by Law.com Radar, ALM's source for immediate alerting on just-filed cases in state and federal courts. Law.com Radar now offers state court coverage nationwide. Sign up today and be among the first to know about new suits in your region, practice area or client sector.View more book results for the query "Janssen Pharmaceutical"
Phila. Mass Tort Over Janssen Bladder Drug Winds Down Without Bellwether Trial
The first trial in the mass tort had been scheduled to begin Monday, but most of the program's cases were resolved through confidential settlements in the last six months, according to Kline & Specter partner Tobi Millrood, who serves as plaintiffs liaison counsel in the matter.Big Law Squares Off in Battle Over Prescription Drug Prices
Courts have consistently rejected challenges under the Takings Clause to federal health care programs that seek to limit costs, according to an amicus curiae brief by a panel of nine nationally recognized experts in Medicare and medical finance.Appeal Dismissed Where Denial of DTSA Seizure Request Was Not an Immediately Appealable Order
Johnson & Johnson, IBM Targeted in Class Action Over Health Care Data Breach
The complaint was first surfaced by Law.com Radar.New Name or Not, Johnson & Johnson Can't Escape Talc Damages
"In other words, regardless of Johnson & Johnson trying to bankrupt their subsidiary, the company that has the assets is ultimately responsible under New Jersey law," Christopher Placitella, who represents plaintiffs in the asbestos litigation, said.Download Now
Download Now
Download Now
Download Now